MARKET

MURA

MURA

Mural Oncology PLC
NASDAQ
1.470
-2.360
-61.62%
Pre Market: 1.510 +0.04 +2.72% 05:23 03/26 EDT
OPEN
1.780
PREV CLOSE
3.830
HIGH
1.820
LOW
1.370
VOLUME
2.68K
TURNOVER
0
52 WEEK HIGH
5.12
52 WEEK LOW
1.370
MARKET CAP
25.33M
P/E (TTM)
-0.1939
1D
5D
1M
3M
1Y
5Y
1D
Mural Oncology halting progress of nemvaleukin trial in ovarian cancer
TipRanks · 1d ago
Mural Oncology downgraded to Hold from Buy at JonesResearch
TipRanks · 1d ago
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
TipRanks · 1d ago
Raymond James downgrades Mural Oncology after ovarian cancer failure
TipRanks · 1d ago
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
TipRanks · 1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 1d ago
Nasdaq Gains 50 Points; US New Home Sales Rise In February
Benzinga · 1d ago
Raymond James downgrades Mural Oncology Plc (MURA) to a Buy
TipRanks · 1d ago
More
About MURA
Mural Oncology plc is Ireland-based clinical-stage oncology company. The Company is leveraging its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer. It leverages its in-cytokine biology, immune cell modulation and protein engineering capabilities to develop immunotherapies. The Company is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. Its portfolio of programs includes Nemvaleukin alfa (Nemvaleukin)-IL-2, IL-12, and IL-18. Nemvaleukin is an engineered interleukin-2 (IL-2) variant designed to harness the potent anti-cancer capabilities of high-dose rhIL-2 while minimizing toxicity by selectively activating cancer-fighting CD8 T cells and NK cells. The tumor-targeted split IL-12 program focuses on delivering the therapeutic potential of IL-12 by splitting it into inactive component.

Webull offers Mural Oncology PLC stock information, including NASDAQ: MURA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MURA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MURA stock methods without spending real money on the virtual paper trading platform.